RNS sooooon7 Jul 2021 08:19
I sent a mail to Cliff on the 30 June and received a reply on 1 July which read “Thank you for your message. I appreciate your concerns, however, be assured we will update the market at the appropriate time on our progress with regards to the SCIB1 and
Modi-1 clinical studies.”
I was very pleased with his fast response, positive tone, and a good sense of humour, which, I had not seen before. This gives me continued confident for the very near term.